cGMPs / QRM Process

Take Our New Survey on FDA-Pharma Manufacturer Relations

We invite you to share your views on how the FDA's move to risk- and science-based regulation is changing plant inspections, interactions with the Agency, and drug manufacturing in general. Ten respondents, selected at random, will earn $50 Starbucks gift cards.

The U.S. Food and Drug Administration (FDA) has moved from a "command and control" approach to regulation, to one guided by the principles of risk management. The Agency is also encouraging drug manufacturers to embrace the principles of science-based manufacturing, quality systems and Quality by Design. This survey will examine how, and whether, this new approach is changing day-to-day interactions and plant inspections. Please take 10 minutes to complete the survey; results will be interpreted in January's issue of Pharmaceutical Manufacturing and on our web site.

Click here to take survey

Free Subscriptions

Pharma Manufacturing Digital Edition

Access the entire print issue on-line and be notified each month via e-mail when your new issue is ready for you. Subscribe Today.

pharmamanufacturing.com E-Newsletters

A mix of feature articles and current new stories that are critical to staying up-to-date on the industry, delivered to your inbox. Choose from an assortment of different topics and frequencies. Subscribe Today.